Eintrag weiter verarbeiten
Characteristics of indirect pharmacodynamic models and applications to clinical drug responses
Gespeichert in:
| Zeitschriftentitel: | British Journal of Clinical Pharmacology |
|---|---|
| Personen und Körperschaften: | , |
| In: | British Journal of Clinical Pharmacology, 45, 1998, 3, S. 229-239 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Sharma, Amarnath Jusko, William J. Sharma, Amarnath Jusko, William J. |
|---|---|
| author |
Sharma, Amarnath Jusko, William J. |
| spellingShingle |
Sharma, Amarnath Jusko, William J. British Journal of Clinical Pharmacology Characteristics of indirect pharmacodynamic models and applications to clinical drug responses Pharmacology (medical) Pharmacology |
| author_sort |
sharma, amarnath |
| spelling |
Sharma, Amarnath Jusko, William J. 0306-5251 1365-2125 Wiley Pharmacology (medical) Pharmacology http://dx.doi.org/10.1046/j.1365-2125.1998.00676.x <jats:p>This review describes four basic physiologic indirect pharmacodynamic response (IDR) models which have been proposed to characterize the pharmacodynamics of drugs that act by indirect mechanisms such as inhibition or stimulation of the production or dissipation of factors controlling the measured effect. The principles underlying IDR models and their response patterns are described. The applicability of these basic IDR models to characterize pharmacodynamic responses of diverse drugs such as inhibition of gastric acid secretion by nizatidine and stimulation of MX protein synthesis by interferon α‐2a is demonstrated. A list of other uses of these models is provided. These models can be readily extended to accommodate additional complexities such as nonstationary or circadian baselines, equilibration delay, depletion or accumulation of a precursor pool, sigmoidicity, or other mechanisms. Indirect response models which have a logical mechanistic basis account for time‐delays in many responses and are widely applicable in clinical pharmacology.</jats:p> Characteristics of indirect pharmacodynamic models and applications to clinical drug responses British Journal of Clinical Pharmacology |
| doi_str_mv |
10.1046/j.1365-2125.1998.00676.x |
| facet_avail |
Online Free |
| finc_class_facet |
Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Ni9qLjEzNjUtMjEyNS4xOTk4LjAwNjc2Lng |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Ni9qLjEzNjUtMjEyNS4xOTk4LjAwNjc2Lng |
| institution |
DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Zi4 DE-Gla1 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-105 DE-Ch1 DE-L229 DE-D275 |
| imprint |
Wiley, 1998 |
| imprint_str_mv |
Wiley, 1998 |
| issn |
0306-5251 1365-2125 |
| issn_str_mv |
0306-5251 1365-2125 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
sharma1998characteristicsofindirectpharmacodynamicmodelsandapplicationstoclinicaldrugresponses |
| publishDateSort |
1998 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
British Journal of Clinical Pharmacology |
| source_id |
49 |
| title |
Characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| title_unstemmed |
Characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| title_full |
Characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| title_fullStr |
Characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| title_full_unstemmed |
Characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| title_short |
Characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| title_sort |
characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| topic |
Pharmacology (medical) Pharmacology |
| url |
http://dx.doi.org/10.1046/j.1365-2125.1998.00676.x |
| publishDate |
1998 |
| physical |
229-239 |
| description |
<jats:p>This review describes four basic physiologic indirect pharmacodynamic response (IDR) models which have been proposed to characterize the pharmacodynamics of drugs that act by indirect mechanisms such as inhibition or stimulation of the production or dissipation of factors controlling the measured effect. The principles underlying IDR models and their response patterns are described. The applicability of these basic IDR models to characterize pharmacodynamic responses of diverse drugs such as inhibition of gastric acid secretion by nizatidine and stimulation of MX protein synthesis by interferon α‐2a is demonstrated. A list of other uses of these models is provided. These models can be readily extended to accommodate additional complexities such as nonstationary or circadian baselines, equilibration delay, depletion or accumulation of a precursor pool, sigmoidicity, or other mechanisms. Indirect response models which have a logical mechanistic basis account for time‐delays in many responses and are widely applicable in clinical pharmacology.</jats:p> |
| container_issue |
3 |
| container_start_page |
229 |
| container_title |
British Journal of Clinical Pharmacology |
| container_volume |
45 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792345825740849166 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:29:37.375Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Characteristics+of+indirect+pharmacodynamic+models+and+applications+to+clinical+drug+responses&rft.date=1998-03-01&genre=article&issn=1365-2125&volume=45&issue=3&spage=229&epage=239&pages=229-239&jtitle=British+Journal+of+Clinical+Pharmacology&atitle=Characteristics+of+indirect+pharmacodynamic+models+and+applications+to+clinical+drug+responses&aulast=Jusko&aufirst=William+J.&rft_id=info%3Adoi%2F10.1046%2Fj.1365-2125.1998.00676.x&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792345825740849166 |
| author | Sharma, Amarnath, Jusko, William J. |
| author_facet | Sharma, Amarnath, Jusko, William J., Sharma, Amarnath, Jusko, William J. |
| author_sort | sharma, amarnath |
| container_issue | 3 |
| container_start_page | 229 |
| container_title | British Journal of Clinical Pharmacology |
| container_volume | 45 |
| description | <jats:p>This review describes four basic physiologic indirect pharmacodynamic response (IDR) models which have been proposed to characterize the pharmacodynamics of drugs that act by indirect mechanisms such as inhibition or stimulation of the production or dissipation of factors controlling the measured effect. The principles underlying IDR models and their response patterns are described. The applicability of these basic IDR models to characterize pharmacodynamic responses of diverse drugs such as inhibition of gastric acid secretion by nizatidine and stimulation of MX protein synthesis by interferon α‐2a is demonstrated. A list of other uses of these models is provided. These models can be readily extended to accommodate additional complexities such as nonstationary or circadian baselines, equilibration delay, depletion or accumulation of a precursor pool, sigmoidicity, or other mechanisms. Indirect response models which have a logical mechanistic basis account for time‐delays in many responses and are widely applicable in clinical pharmacology.</jats:p> |
| doi_str_mv | 10.1046/j.1365-2125.1998.00676.x |
| facet_avail | Online, Free |
| finc_class_facet | Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Ni9qLjEzNjUtMjEyNS4xOTk4LjAwNjc2Lng |
| imprint | Wiley, 1998 |
| imprint_str_mv | Wiley, 1998 |
| institution | DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229, DE-D275 |
| issn | 0306-5251, 1365-2125 |
| issn_str_mv | 0306-5251, 1365-2125 |
| language | English |
| last_indexed | 2024-03-01T17:29:37.375Z |
| match_str | sharma1998characteristicsofindirectpharmacodynamicmodelsandapplicationstoclinicaldrugresponses |
| mega_collection | Wiley (CrossRef) |
| physical | 229-239 |
| publishDate | 1998 |
| publishDateSort | 1998 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | British Journal of Clinical Pharmacology |
| source_id | 49 |
| spelling | Sharma, Amarnath Jusko, William J. 0306-5251 1365-2125 Wiley Pharmacology (medical) Pharmacology http://dx.doi.org/10.1046/j.1365-2125.1998.00676.x <jats:p>This review describes four basic physiologic indirect pharmacodynamic response (IDR) models which have been proposed to characterize the pharmacodynamics of drugs that act by indirect mechanisms such as inhibition or stimulation of the production or dissipation of factors controlling the measured effect. The principles underlying IDR models and their response patterns are described. The applicability of these basic IDR models to characterize pharmacodynamic responses of diverse drugs such as inhibition of gastric acid secretion by nizatidine and stimulation of MX protein synthesis by interferon α‐2a is demonstrated. A list of other uses of these models is provided. These models can be readily extended to accommodate additional complexities such as nonstationary or circadian baselines, equilibration delay, depletion or accumulation of a precursor pool, sigmoidicity, or other mechanisms. Indirect response models which have a logical mechanistic basis account for time‐delays in many responses and are widely applicable in clinical pharmacology.</jats:p> Characteristics of indirect pharmacodynamic models and applications to clinical drug responses British Journal of Clinical Pharmacology |
| spellingShingle | Sharma, Amarnath, Jusko, William J., British Journal of Clinical Pharmacology, Characteristics of indirect pharmacodynamic models and applications to clinical drug responses, Pharmacology (medical), Pharmacology |
| title | Characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| title_full | Characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| title_fullStr | Characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| title_full_unstemmed | Characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| title_short | Characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| title_sort | characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| title_unstemmed | Characteristics of indirect pharmacodynamic models and applications to clinical drug responses |
| topic | Pharmacology (medical), Pharmacology |
| url | http://dx.doi.org/10.1046/j.1365-2125.1998.00676.x |